Variants in the Toll-Like Receptor Signaling Pathway and Clinical Outcomes of Malaria

dc.creatorLeoratti, Fabiana M. S.
dc.creatorFarias, Lilian
dc.creatorAlves, Fabiana P.
dc.creatorSuarez-Mutis, Martha C.
dc.creatorCoura, José Rodrigues
dc.creatorKalil, Jorge
dc.creatorCamargo, Erney P.
dc.creatorMoraes, Sandra L.
dc.creatorRamasawmy, Rajendranath
dc.date2019-04-25T17:12:32Z
dc.date2019-04-25T17:12:32Z
dc.date2008
dc.date.accessioned2023-09-26T22:15:58Z
dc.date.available2023-09-26T22:15:58Z
dc.identifierLEORATTI, Fabiana M. S. et al. Variants in the Toll-Like Receptor Signaling Pathway and Clinical Outcomes of Malaria. The Journal of Infectious Diseases, v. 198, p. 772-780, 2008.
dc.identifier0022-1899
dc.identifierhttps://www.arca.fiocruz.br/handle/icict/32753
dc.identifier10.1086/590440
dc.identifier1537-6613
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/8877050
dc.descriptionMalaria is one of the most significant infectious diseases in the world and is responsible for a large proportion of infant deaths. Toll-like receptors (TLRs), key components of innate immunity, are central to countering infection. Variants in the TLR-signaling pathway are associated with susceptibility to infectious diseases.
dc.description2022-01-01
dc.formatapplication/pdf
dc.languageeng
dc.publisherOxford University Press
dc.rightsrestricted access
dc.subjectMalária
dc.subjectResultados clínicos
dc.subjectReceptor do tipo Toll
dc.subjectSinalização
dc.subjectMalaria
dc.subjectClinical Outcomes
dc.subjectToll-Like Receptor
dc.subjectVariants
dc.subjectSignaling Pathway
dc.titleVariants in the Toll-Like Receptor Signaling Pathway and Clinical Outcomes of Malaria
dc.typeArticle


Este ítem pertenece a la siguiente institución